| Parnax Lab Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506128 |
NSE Symbol : - |
P/E(TTM) : 171.07 |
|
ISIN Demat : INE383L01019 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.70 |
|
Book Value(₹) : 20.26 |
Market Cap(₹Cr) : 137.54 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1.70 | 1.97 | 0.84 | 0.99 | 1.54 | 3.66 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1.70 | 1.97 | 0.84 | 0.99 | 1.54 | 3.66 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.20 | 0.19 | 0.19 | 0.17 | 0.18 | 0.17 |
| Total Income | 1.90 | 2.15 | 1.03 | 1.15 | 1.72 | 3.83 |
| Total Expenditure | 1.20 | 1.81 | 1.12 | 0.92 | 1.34 | 2.41 |
| PBIDT | 0.69 | 0.34 | -0.09 | 0.23 | 0.38 | 1.43 |
| Interest | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| PBDT | 0.68 | 0.33 | -0.10 | 0.22 | 0.38 | 1.42 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.17 | 0.08 | -0.03 | 0.05 | 0.09 | 0.35 |
| Reported Profit After Tax | 0.49 | 0.23 | -0.08 | 0.16 | 0.27 | 1.05 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.49 | 0.23 | -0.08 | 0.16 | 0.27 | 1.05 |
| EPS (Unit Curr.) | 0.43 | 0.20 | -0.07 | 0.14 | 0.24 | 0.91 |
| EPS (Adj) (Unit Curr.) | 0.43 | 0.20 | -0.07 | 0.14 | 0.24 | 0.91 |
| Calculated EPS (Unit Curr.) | 0.43 | 0.20 | -0.07 | 0.14 | 0.24 | 0.91 |
| Calculated EPS (Adj) (Unit Curr.) | 0.43 | 0.20 | -0.07 | 0.14 | 0.24 | 0.91 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.72 | 0.82 | -0.29 | 0.55 | 0.94 | 3.66 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.72 | 0.82 | -0.29 | 0.55 | 0.94 | 3.66 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 | 11.49 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 10.99 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 40.59 | 17.26 | -10.71 | 23.23 | 24.68 | 39.07 |
| PBDTM(%) | 40.00 | 16.75 | -11.90 | 22.22 | 24.68 | 38.80 |
| PATM(%) | 28.82 | 11.68 | -9.52 | 16.16 | 17.53 | 28.69 |